Ponoi Capital, LP
CIK 0001707230 Name as filed on the most recent filing
Filed as Ponoi Capital, LP (78)
209 transaction lines · from 78 filings · filed 2017-10-30 to 2023-11-17 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
- ISSUER NGM Biopharmaceuticals Inc 62 filings
- ISSUER Rapt Therapeutics, Inc. 11 filings
- ISSUER Constellation Pharmaceuticals Inc 3 filings
- ISSUER Revolution Medicines, Inc. 1 filings
- ISSUER Immune Design Corp. 1 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2022-05-13 |
NGM Biopharmaceuticals Inc NGM |
P, Open-market purchase | 125,096 acquired | Not reported | Not priced | Form 4, filing 0000899243-22-018399 | |
| 2022-05-13 |
NGM Biopharmaceuticals Inc NGM |
P, Open-market purchase | 4,269 acquired | Not reported | Not priced | Form 4, filing 0000899243-22-018399 | |
| 2022-05-12 |
NGM Biopharmaceuticals Inc NGM |
P, Open-market purchase | 79,945 acquired | 11.62 | 929,048.84 | Form 4, filing 0000899243-22-018030 | |
| 2022-05-12 |
NGM Biopharmaceuticals Inc NGM |
P, Open-market purchase | 2,728 acquired | 11.62 | 31,702.36 | Form 4, filing 0000899243-22-018030 | |
| 2022-05-12 |
NGM Biopharmaceuticals Inc NGM |
P, Open-market purchase | 485 acquired | 11.81 | 5,725.76 | Form 4, filing 0000899243-22-018030 | |
| 2022-05-12 |
NGM Biopharmaceuticals Inc NGM |
P, Open-market purchase | 17 acquired | 11.81 | 200.70 | Form 4, filing 0000899243-22-018030 | |
| 2022-05-11 |
NGM Biopharmaceuticals Inc NGM |
P, Open-market purchase | 77,866 acquired | 11.23 | 874,108.14 | Form 4, filing 0000899243-22-018030 | |
| 2022-05-11 |
NGM Biopharmaceuticals Inc NGM |
P, Open-market purchase | 2,657 acquired | 11.23 | 29,826.95 | Form 4, filing 0000899243-22-018030 | |
| 2022-05-11 |
NGM Biopharmaceuticals Inc NGM |
P, Open-market purchase | 2,564 acquired | 11.85 | 30,376.48 | Form 4, filing 0000899243-22-018030 | |
| 2022-05-11 |
NGM Biopharmaceuticals Inc NGM |
P, Open-market purchase | 88 acquired | 11.85 | 1,042.56 | Form 4, filing 0000899243-22-018030 | |
| 2022-05-10 |
Rapt Therapeutics, Inc. RAPT |
P, Open-market purchase | 1,208,750 acquired | 10.67 | 12,899,175.62 | Form 4, filing 0000899243-22-017787 | |
| 2022-05-10 |
Rapt Therapeutics, Inc. RAPT |
P, Open-market purchase | 41,250 acquired | 10.67 | 440,199.38 | Form 4, filing 0000899243-22-017787 | |
| 2022-05-10 |
NGM Biopharmaceuticals Inc NGM |
P, Open-market purchase | 30,233 acquired | 11.36 | 343,555.72 | Form 4, filing 0000899243-22-017672 | |
| 2022-05-10 |
NGM Biopharmaceuticals Inc NGM |
P, Open-market purchase | 1,032 acquired | 11.36 | 11,727.24 | Form 4, filing 0000899243-22-017672 | |
| 2022-05-09 |
NGM Biopharmaceuticals Inc NGM |
P, Open-market purchase | 80,430 acquired | 10.79 | 868,072.95 | Form 4, filing 0000899243-22-017672 | |
| 2022-05-09 |
NGM Biopharmaceuticals Inc NGM |
P, Open-market purchase | 2,745 acquired | 10.79 | 29,626.51 | Form 4, filing 0000899243-22-017672 | |
| 2022-01-25 |
NGM Biopharmaceuticals Inc NGM |
P, Open-market purchase | 579,910 acquired | Not reported | Not priced | Form 4, filing 0000899243-22-003318 | |
| 2022-01-25 |
NGM Biopharmaceuticals Inc NGM |
P, Open-market purchase | 19,791 acquired | Not reported | Not priced | Form 4, filing 0000899243-22-003318 | |
| 2022-01-24 |
NGM Biopharmaceuticals Inc NGM |
P, Open-market purchase | 241,750 acquired | Not reported | Not priced | Form 4, filing 0000899243-22-003318 | |
| 2022-01-24 |
NGM Biopharmaceuticals Inc NGM |
P, Open-market purchase | 8,250 acquired | Not reported | Not priced | Form 4, filing 0000899243-22-003318 | |
| 2021-09-27 |
Rapt Therapeutics, Inc. RAPT |
S, Open-market sale | 7,500 disposed | 34.48 | 258,606.00 | Form 4, filing 0000899243-21-038196 | |
| 2021-09-27 |
Rapt Therapeutics, Inc. RAPT |
S, Open-market sale | 1,114 disposed | 34.96 | 38,951.01 | Form 4, filing 0000899243-21-038196 | |
| 2021-09-27 |
Rapt Therapeutics, Inc. RAPT |
S, Open-market sale | 625 disposed | 34.94 | 21,840.38 | Form 4, filing 0000899243-21-038196 | |
| 2021-09-15 |
Rapt Therapeutics, Inc. RAPT |
S, Open-market sale | 12,939 disposed | 37.22 | 481,633.57 | Form 4, filing 0000899243-21-036293 | |
| 2021-09-15 |
Rapt Therapeutics, Inc. RAPT |
S, Open-market sale | 11,476 disposed | 37.21 | 427,065.57 | Form 4, filing 0000899243-21-036293 | |
| 2021-09-15 |
Rapt Therapeutics, Inc. RAPT |
S, Open-market sale | 4,720 disposed | 37.70 | 177,957.22 | Form 4, filing 0000899243-21-036293 | |
| 2021-09-15 |
Rapt Therapeutics, Inc. RAPT |
S, Open-market sale | 4,400 disposed | 37.67 | 165,762.08 | Form 4, filing 0000899243-21-036293 | |
| 2021-09-14 |
Rapt Therapeutics, Inc. RAPT |
S, Open-market sale | 42,151 disposed | 36.92 | 1,556,046.32 | Form 4, filing 0000899243-21-036293 | |
| 2021-09-14 |
Rapt Therapeutics, Inc. RAPT |
S, Open-market sale | 32,211 disposed | 36.85 | 1,187,065.54 | Form 4, filing 0000899243-21-036293 | |
| 2021-09-14 |
Rapt Therapeutics, Inc. RAPT |
S, Open-market sale | 29,634 disposed | 36.79 | 1,090,142.99 | Form 4, filing 0000899243-21-036293 | |
| 2021-09-14 |
Rapt Therapeutics, Inc. RAPT |
S, Open-market sale | 25,351 disposed | 37.27 | 944,844.45 | Form 4, filing 0000899243-21-036293 | |
| 2021-09-14 |
Rapt Therapeutics, Inc. RAPT |
S, Open-market sale | 10,807 disposed | 37.31 | 403,261.04 | Form 4, filing 0000899243-21-036293 | |
| 2021-09-14 |
Rapt Therapeutics, Inc. RAPT |
S, Open-market sale | 2,926 disposed | 37.31 | 109,157.94 | Form 4, filing 0000899243-21-036293 | |
| 2021-09-14 |
Rapt Therapeutics, Inc. RAPT |
S, Open-market sale | 1,700 disposed | 35.77 | 60,814.44 | Form 4, filing 0000899243-21-036293 | |
| 2021-09-14 |
Rapt Therapeutics, Inc. RAPT |
S, Open-market sale | 1,496 disposed | 35.75 | 53,476.91 | Form 4, filing 0000899243-21-036293 | |
| 2021-09-14 |
Rapt Therapeutics, Inc. RAPT |
S, Open-market sale | 1,400 disposed | 35.71 | 49,989.94 | Form 4, filing 0000899243-21-036293 | |
| 2021-09-13 |
Rapt Therapeutics, Inc. RAPT |
S, Open-market sale | 4,803 disposed | 35.25 | 169,308.63 | Form 4, filing 0000899243-21-035845 | |
| 2021-09-13 |
Rapt Therapeutics, Inc. RAPT |
S, Open-market sale | 4,788 disposed | 35.28 | 168,942.19 | Form 4, filing 0000899243-21-035845 | |
| 2021-09-13 |
Rapt Therapeutics, Inc. RAPT |
S, Open-market sale | 4,726 disposed | 35.27 | 166,692.16 | Form 4, filing 0000899243-21-035845 | |
| 2021-09-10 |
Rapt Therapeutics, Inc. RAPT |
S, Open-market sale | 7,320 disposed | 35.19 | 257,572.50 | Form 4, filing 0000899243-21-035845 | |
| 2021-09-10 |
Rapt Therapeutics, Inc. RAPT |
S, Open-market sale | 7,231 disposed | 35.19 | 254,494.32 | Form 4, filing 0000899243-21-035845 | |
| 2021-09-10 |
Rapt Therapeutics, Inc. RAPT |
S, Open-market sale | 7,187 disposed | 35.19 | 252,940.00 | Form 4, filing 0000899243-21-035845 | |
| 2021-09-02 |
Rapt Therapeutics, Inc. RAPT |
S, Open-market sale | 18,556 disposed | 35.43 | 657,468.77 | Form 4, filing 0000899243-21-035109 | |
| 2021-09-02 |
Rapt Therapeutics, Inc. RAPT |
S, Open-market sale | 18,545 disposed | 35.43 | 657,082.73 | Form 4, filing 0000899243-21-035109 | |
| 2021-09-01 |
Rapt Therapeutics, Inc. RAPT |
S, Open-market sale | 8,976 disposed | 35.39 | 317,674.10 | Form 4, filing 0000899243-21-035109 | |
| 2021-09-01 |
Rapt Therapeutics, Inc. RAPT |
S, Open-market sale | 8,805 disposed | 35.06 | 308,681.29 | Form 4, filing 0000899243-21-035109 | |
| 2021-09-01 |
Rapt Therapeutics, Inc. RAPT |
S, Open-market sale | 7,064 disposed | 35.46 | 250,483.79 | Form 4, filing 0000899243-21-035109 | |
| 2021-09-01 |
Rapt Therapeutics, Inc. RAPT |
S, Open-market sale | 6,904 disposed | 35.02 | 241,752.54 | Form 4, filing 0000899243-21-035109 | |
| 2021-08-24 |
Rapt Therapeutics, Inc. RAPT |
S, Open-market sale | 7,100 disposed | 31.77 | 225,532.21 | Form 4, filing 0000899243-21-034085 | |
| 2021-08-24 |
Rapt Therapeutics, Inc. RAPT |
S, Open-market sale | 4,318 disposed | 30.94 | 133,602.37 | Form 4, filing 0000899243-21-034085 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- P, Open-market purchase
- Open-market purchase
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. PONOI CAPITAL, LP, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001707230
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6